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ARTIFICIAL SWEETENERS AND PERCEIVED OBESITY AND DIABETES 
YEACHAN KIM 
ABSTRACT 
 
 Artificial sweeteners have been increasingly incorporated into our diets. Contrary 
to what is believed to alleviate the obesity and diabetes epidemic seen today, artificial 
sweeteners have shown to induce the very problem it was meant to repress. Studies found 
that the consumption of artificial sweeteners ultimately lead to an increased risk of 
weight gain and diabetes. Exposure has shown to induce problems ranging from 
dysbiosis, inflammation, overconsumption, metabolic derangements, and much more that 
highly suggests the counterintuitive effects of artificial sweeteners. 
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INTRODUCTION 
 Saccharin was the very first artificial sweetener to be discovered by Professors 
Fahlberg and Remsen (Echhardt et al, 1980). The use of artificial sweeteners has become 
widely popularized as a sugar substitute since the turn of the 20th century (Arnold, 
Krewski & Munro, 1983). As of this date, the Food and Drug Administration (FDA) has 
approved six different artificial sweeteners for the human use of consumption. 
 
 
Table 1. Six artificial sweeteners approved by FDA. FDA approved sweeteners with 
an acceptable daily intake (ADI), which is the amount of sweetener deemed safe for daily 
consumption (Sylvetsky, Rother & Brown, 2011). 
 
However, there have been multiple controversies surrounding the use of artificial 
sweeteners as part of a regular diet. In a series of studies conducted in 1977, researchers 
found a positive correlation between intake of saccharin and the rate of bladder cancer 
formation in rats (Hicks & Chowaniec, 1977). These findings led to the temporary ban of 
saccharin use by the FDA, but was overturned due to the lack of evidence and association 
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of cancer formation in the human bladder (Kessler & Clark 1978). In addition, a 
prospective cohort study showed that daily intake of artificially sweetened soft drinks 
was linked to increased risk of stroke and dementia (Pase et al, 2017). Moreover, several 
other conditions such as cardiovascular disease and metabolic disorders have been listed 
as potential risks when consuming artificial sweeteners (Dhingra et al, 2007). But 
amongst all these potential associated risks, obesity and diabetes have been one of the 
more prevalent risks linked to artificial sweeteners. 
 Generally, artificial sweeteners are considered to be healthy alternatives to sugar, 
contributing zero calories while providing the same sweet taste that conventional sugar 
gives (FDA, 2015). Over the past 3 decades, the consumption of artificial sweeteners 
increased significantly as well: 
	3 
 
Table 2. Trend in intake of food and beverage containing NNS. There is an increasing 
trend in the consumption of non-nutritive sweetener (NNS) through food and beverage 
among Americans aged ³ 2 years old (Mattes & Popkin, 2009). 
  
 Increased trend in the consumption of artificial sweetener is observed among all 
age groups, socioeconomic backgrounds, and race (Sylvetsky et al, 2012). Specifically, 
the most dramatic increase in consumption rate in the United States could be seen among 
females, non-Hispanic black children, and Hispanic adults (Sylvetsky et al, 2012). As 
show in table 2 above, 15.1% of total US population would consume artificial sweetened 
food or beverage on a given day, compared to 2.5% in 1965 (Mattes & Popkin, 2009). 
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Although artificial sweeteners are deemed safe and great alternative for diabetic 
and obese patients, there has been many contradictory findings across the research field. 
Consumption of artificial sweeteners have shown to have damaging effects through 
inducing glucose intolerance (specifically linked to type 2 diabetes) by altering the gut 
microbiota (Suez et al, 2014). In a similar fashion, consumption of artificial sweeteners 
has shown to promote energy intake behaviors, showing an indirect link to obesity and 
diabetes as well (Mattes & Popkin 2009). However, in the midst of these findings linking 
artificial sweeteners to obesity and diabetes, several studies found that the correlation was 
inconclusive due to lack of evidence and limitations on studies (Gardner et al, 2012; 
Pepino 2015; Canty & Chan 1991). 
Despite all these misconceptions and contradictory results, there are significant 
evidence that links artificial sweeteners to obesity and diabetes. Unlike what was 
expected of the artificial sweeteners to provide weight loss and a solution to obesity, the 
effects are often counterintuitive. This thesis will look at several specific studies and 
mechanisms showing that there is a strong correlation that links artificial sweeteners to 
obesity and diabetes. 
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Specific Aims 
Specific Aim of this thesis is to identify and review previously published studies and 
mechanisms that show positive correlation of artificial sweetener consumption to obesity 
and diabetes: 
1. Alterations to the gut microbiota leading to weight gain and diabetic 
conditions 
2. Metabolic changes that occur through consumption of artificial sweeteners 
3. Associated behavioral change leading to energy consumption or imbalance
	6 
Effects of Artificial Sweeteners on Gut Microbiota 
 As artificial sweeteners (i.e. saccharin) are passed through the digestive system, it 
is undigested and not metabolized (Byard & Goldberg, 1973). However, these artificial 
sweeteners are left directly to interact with the gut microbiota (John, Wood & Hawkins, 
2000). Gut microbiota has a profound effect on human health and alterations to these 
cells can lead to metabolic and immune disorders in both animals and humans alike 
(Boulangé et al, 2016). 
A recent study in 2014 has shown that intake of artificial sweeteners does indeed 
alter gut microbiota (Suez et al, 2014). The first series of studies were done on 10-week-
old C57Bl/6 mice (Suez et al, 2014). To see the effects of artificial sweeteners on these 
mice, three groups were created (Suez et al, 2014). Two of the three groups were control 
groups with one mice group drinking only water and the other control group drinking 
water enhanced with either glucose or sucrose (Suez et al, 2014). The experimental group 
received water with a selection of saccharin, sucralose, and aspartame (Suez et al, 2014). 
The experimental group showed the greatest glucose intolerance while control groups 
showed similar glucose tolerance curves as seen in figure 1 below (Suez et al, 2014). 
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Figure 1. Oral Glucose Tolerance Test (Week 11). Experimental group drinking water 
mixed with artificial sweetener showed the greatest glucose intolerance (Suez et al, 2014). 
 
In addition to the mice study, Suez and colleagues collected and analyzed the 
fecal compositions of the mouse groups (Suez et al, 2014). Mice drinking water treated 
with artificial sweetener showed distinct microbiota composition when compared to the 
control groups (Suez et al, 2014). These fecal microbiota samples were also cultured in 
an anaerobic environment in presence of saccharin or the respective control group media 
(Suez et al, 2014). The saccharin treated microbiota was then transferred to germ-free 
mice, which resulted in markedly higher glucose intolerance when compared to germ-free 
mice treated with the control group fecal samples (Figure 2a) (Suez et al, 2014). The 
composition of the bacteria also differed significantly. The stool culture of the saccharin 
treated mice showed an increase in the Bacteroidetes and also the reduction in the 
Firmicutes (Figure 2b) (Suez et al, 2014). Studies show that the misbalance of these two 
phyla is associated with obesity (Turnbaugh et al, 2006). In sum, the results of oral 
administration of artificial sweeteners and in vitro experimentations using fecal samples 
showcases that artificial sweeteners alters the gut microbiota, leading to dysbiosis and 
glucose intolerance in that mammal (Suez et al, 2014). 
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Figure 2. Saccharin’s effect on gut microbiota. Figure 2a shows the timeline of in vitro 
experiment using fecal sample of the control group and the experimental group. Figure 2b 
shows the stool sample composition. Figure 3c shows the glycemic response of the 
treated mice (Suez et al, 2014). 
 
 A similar experiment took part in 2017, where 10 male and 10 female mice were 
given either water (control) or acesulfame-k (ace-k) enriched water (Bian et al, 2017) for 
the duration of 4 weeks. It was shown that ace-k enriched water produced dysbiosis in the 
gut and resulted in weight gain (Bian et al, 2017). However, only the male mice resulted 
in weight gain while the female mice showed very minimal changes, suggesting a gender 
specific reaction to the artificial sweetener (Figure 3) (Bian et al, 2017). 
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Figure 3. Gender specific response of mice to artificial sweeteners. Ace-k treatment in 
male mice showed significant weight change while female mice showed minimal changes. 
Treatments also led to upregulation of multiple genes associated with pro-inflammatory 
mediators, suggesting liver and tissue inflammation in response to artificial sweeteners 
(Bian et al, 2017). 
  
After the conclusion of studies with mice, which may yield unique results, follow 
up studies were done to test artificial sweeteners in human subjects (Suez et al, 2014). 
Seven volunteers consumed the acceptable daily intake of saccharin (5mg/kg of body 
weight) from days 2-7 (Suez et al, 2014). 4 of the 7 individuals developed glucose 
intolerance in this short period of time, and they were termed Non-caloric Artificial 
Sweetener (NAS) Responders (Suez et al, 2014). The remaining 3 individuals did not 
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show statistically significant changes in their glucose tolerance, and they were termed 
NAS non-responders (Suez et al, 2014).  
 
 
Figure 4. Effects of artificial sweeteners on human participants. Figure 3c shows the 
NAS responders’ development of glucose intolerance. Figure 3d shows minimal changes 
for NAS non-responders. Figure 3ef shows clear changes in microbiome composition of 
NAS responders while minimal change was observed in NAS non-responders (Suez et al, 
2014). 
 
 The differing results seen by the NAS responders and NAS non-responders show 
that humans have a personalized response to artificial sweeteners, mainly due to the 
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contrast in the composition of each microbiota (Suez et al, 2014). Bian and colleagues 
has shown that there exist multiple factors to explain such a phenomenon such as gender-
specific responses of the gut microbiome to artificial sweeteners (Bian et al, 2017). 
Collectively, these findings suggest that the increase in consumption of artificial 
sweeteners directly correlates to the increase seen in obesity and diabetes. 
  
Observed Adverse Effects of Artificial Sweeteners 
As many would speculate, foods that are high in sugars and sweeteners have been 
linked with an increase in the incidence of various adverse health effects. Studies have 
shown that consumption of sweet drinks and sweetened substances often led to higher 
incidents of type 2 diabetes (O’Connor et al, 2015). However, multiple studies have 
implicated non-caloric sweeteners to actually induce weight gain while others have 
identified specific factors that may be secondary effects ultimately caused by the 
sweeteners. Due to the highly accepted reality of sucrose and other normal sugars being 
so closely linked to issues such as weight gain and diabetes, the fact that the artificial 
sweeteners may also indirectly lead to the same underlying issues that people were trying 
to avoid is quiet alarming. 
 
Weight Changes Following Consuming Artificial Sweeteners 
The immediate benefits of artificial sweeteners seem to be that it intuitively 
causes weight loss due to the absence of caloric values in the substance consumed. Miller 
and Perez found a rather positive and favorable outcome in terms of weight loss when 
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low-calorie sweeteners replaced normal sweeteners (Miller & Perez, 2014). In 
overweight individuals, similar results were observed when given a trial period of 10 
weeks of sucrose or artificial sweetener (Raben et al, 2002). Individuals who consumed 
the artificial sweetener were less likely to manifest adverse effects such as high blood 
pressure and fat mass (Raben et al, 2002). However, there have still been many 
contradictory studies and outcomes that has suggested that weight loss is not always the 
predicted outcome (Stellman & Garfinkel, 1988; Andrejic et al, 2013) 
In terms of the obesity, the results were many times counter-intuitive to what was 
expected. It was reasonable to assume that by using artificial sweeteners, there would be 
a lower BMI due to the absence of calories (Gardner et al, 2012). However, the results 
were rather surprising. In a study conducted by Fowler and colleagues, the relationship 
between the consumption of artificial sweeteners and weight gain were measured in a 
population of Mexican Americans and non-Hispanic white individuals (Fowler et al, 
2008). Exercise frequency and dietary intake of food was recorded daily (Fowler et al, 
2008). Overall, instead of a decrease in BMI, there was actually an increase in the BMI of 
the individuals following documented use of artificial sweeteners (Fowler et al, 2008). In 
mice, similar results have been measured with a greater increase of weight following 
consumption of a solution of artificial sweeteners (Polyak et al, 2010). Polyak and 
colleagues noted that despite the weight gain in groups of mice that were given artificial 
sweeteners relative to control groups that did not have the artificial sweetener, the weight 
increased even without increasing the amount of food intake (Polyak et al, 2010). 
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Table 3.  Consumption of artificial sweeteners and BMI. Participants who consumed 
more artificial sweeteners had higher BMI measures. (Fowler et al, 2008) 
 
Swithers, Sample and Davidson found that the predispositions also mattered in 
determining whether or not weight gain was observed (Swithers, Sample and Davidson, 
2013). Rats that were fed a diet that was maintained by a lower fat content did not gain 
significantly more weight when comparing between a supplement with saccharin fed 
group and a supplement with glucose fed group (Swithers, Sample and Davidson, 2013). 
However, a secondary group of rats that were fed a “Westernized” diet that was higher in 
fat content did have a difference in the amount of fat that was gained between the sucrose 
supplement group and the saccharin fed group (Swithers, Sample and Davidson, 2013). 
The female rats that were fed the Westernized diet initially and given the saccharine 
supplement had a significant change in weight and body fat content with a greater 
increase compared to the glucose supplement group (Swithers, Sample, and Davidson, 
2013).  
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Figure 5. The effect of either sucrose or saccharine solutions on the cumulative 
weight gain. Rats who consumed saccharine had a higher weight gain compared to the 
sucrose group (Pinto et al, 2017).  
 
Laverty and colleagues found, in British children, that boys tended to consume 
more artificial sweeteners than girls at the age of approximately 11 years (Laverty et al, 
2015). Participants recorded the types of food consumed and the amount exercise that 
was taken on a given day (Laverty et al, 2015). Variety of factors were controlled, such 
as dietary behaviors, physical activities, sex, ethnic group, and socioeconomic 
backgrounds (Laverty et al, 2015). Following an increased consumption of the artificially 
sweetened substances, increase in fat content or adiposity was observed throughout 
children age 7 to 11 (Laverty et al, 2015).  Multiple studies have shown the tendencies of 
artificial sweeteners to be connected with a higher measured waist measurement. In a 
recent study by Fowler, Williams and Hazuda, the waist circumference of people who 
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had a history of consumption of diet sodas were shown to be significantly larger than the 
individuals who did not drink the diet sodas (Fowler, Williams & Hazuda, 2015). Chia 
and colleagues showed the same results of a larger waste and increased incidence of 
abdominal obesity in a study of individuals with chronic use of artificial sweeteners (Chia 
et al, 2016). Figure below shows LCS users, solid lines, with increased abdominal obesity 
when compared to non LCS users represented by the dotted line (Chia et al, 2016). 
 
 
 
Figure 6. Years since the baseline and the cumulative increase in the abdominal 
obesity.  There is an increasing trend for abdominal obesity when consuming artificial 
sweeteners in comparison with those that did not chronically consume it. Chronic low-
calorie sweetener users had a higher baseline of abdominal obesity relative to individuals 
who did not have an extensive history of chronic use. (Chia et al, 2016) 
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Diabetes and Metabolic Issues 
In one report by de Koning and colleagues, a prospective study was conducted on 
a cohort of men over a course of 20 years (de Koning et al, 2011). The type of beverage 
consumption and the frequency was tracked using questionnaires and the cases of type 2 
diabetes that arose were tracked and documented (de Koning et al, 2011). Compared to 
the group that consumed regular sweetened beverages such as juices, the group that 
engaged in consumption of beverages with an artificial sweetener had a significantly 
lower incidence of diabetes (de Koning et al, 2011).  For women who consumed a higher 
frequency of sugary beverages, the incident of type 2 diabetes was also observed in a 
study conducted by Schulze and colleagues (Schulze et al, 2004). However, this 
relationship has had also very conflicting results in others studies (Fagherazzi et al, 2013). 
Multiple clinical studies have shown that when participants consumed artificial 
sweeteners, there was not much difference in outcome for diabetes with another group 
that consumed normal sweeteners. Both sweeteners and non-caloric sweeteners 
seemingly could lead to increased cases of diabetes. In a French study conducted by 
Fagherazzi and colleagues, a population of French women were chosen to be tracked for 
their consumption of either fruit juice, beverages that were artificially sweetened, or 
sugar sweetened drinks over a 14 year period (Fagherazzi et al, 2013). Both women who 
consumed sugar sweetened and artificially sweetened beverages had an increase in the 
cases of type 2 diabetes that was documented (Fagherazzi et al, 2013). Huang and 
colleagues also found that in a population of postmenopausal women, there was a higher 
incidence of type-2 diabetes when participants consumed artificial sweeteners or sugar 
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sweeteners (Huang et al, 2017). This general trend towards diabetes was only combatted 
when the artificially substituted and regularly substituted drinks were replaced with 
regular water (Huang et al, 2017).  
Kuk and Brown found that obese patients were found to be more susceptible to 
issues with diabetes following consumption of artificial sweeteners (Kuk and Brown, 
2016). Individuals who were obese had a higher likelihood of demonstrating glucose 
intolerance, which likely led to these results (Kuk and Brown, 2016). It was also 
documented by Nettleton and colleagues that the consumption of diet sodas was also 
associated with a higher likelihood of developing either type 2 diabetes or metabolic 
syndrome (Nettleton et al, 2009). Although metabolic issues changed according to other 
factors such as the adiposity of subjects, Nettleton and colleagues found that type-2 
diabetes was independent of these factors and mainly seemed to be influenced by the diet 
sodas (Nettleton et al, 2009). 
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Table 4. The incidents of Type 2 diabetes and metabolic syndrome with 
consumption of diet sodas. Participants who drank more diet soda had higher incidents 
of developing type 2 diabetes. Factors controlled were age, sex, race/ethnicity, 
socioeconomic status, and energy intake (Nettleton et al, 2009). 
 
 
Figure 7. Obesity and glucose intolerance. Participants who received the aspartame 
non-caloric sweetener had higher glucose intolerance when they had a higher BMI. (Kuk 
and Brown, 2016) 
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Figure 8. Body Mass Index and glucose intolerance following the consumption of the 
non-caloric sweetener saccharin. There was a parallel increase of the intolerance 
between both the control and the experimental groups. Both groups increased intolerance 
with increasing BMI. 2856 adults tested (Kuk and Brown, 2016). 
 
From histological studies of rodent models, there has been more insight into the 
reasons for the difference biological outcomes between the artificial sweetener groups 
and the group without an artificial sweetener. According to a study conducted by 
Andrejic and colleagues, the regions of the pancreas were different between the saccharin 
group and the non-saccharine group (Andrejic et al, 2013). The densities of the exocrine 
acini and the islets of Langerhans, both critical to the function of the metabolism, were 
greater in the saccharine group (Andrejic et al, 2013). Furthermore, other markers such as 
the enzyme aspartate transaminase (AST) were greater for the saccharine group (Andrejic 
et al, 2013). In addition, the levels of glucose were much higher in the saccharine treated 
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group relative to the control group that was not exposed to the artificial sweetener 
(Andrejic et al, 2013).  
 
Figure 9. Weight of saccharine exposed vs non-saccharine exposed group over a 6 
week duration. The saccharine group had a higher weight compared to the control group 
(Andrejic et al, 2013). 
 
 
	21 
 
Figure 10. Pancreatic images of saccharine exposed rodents. The pancreas of a male 
rodent following continued use of saccharine as a sweetener.  (Andrejic et al, 2013).  
 
 
 
Figure 11. Image of the pancreas for a control group rodent that did not consumed 
the artificial sweetener saccharine. (Andrejic et al, 2013).  
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Non-Superficial Biological Consequences 
             From multiple studies, the biological implications following consumption of 
artificial sweeteners have been rather alarming. Jang, Jeoung and Cho studied the 
consequential nature of artificial sweeteners on a modified version of apolipoprotein A-I 
and the causative effects (Jang, Jeoung, & Cho, 2011). According to the findings of the 
study, effects of sugar fructose and artificial sweeteners were measured by assessing the 
high-density lipoproteins (HDL) along with apolipoprotein A-I (Jang, Jeoung, & Cho, 
2011). Due to the protective effects of both the HDL and the apolipoprotein A-I, any 
negative change would lead to adverse effects on both atherosclerosis progression along 
with early senescence (Jang, Jeoung, and Cho, 2011). In patients diagnosed with human 
immunodeficiency virus (HIV), the adverse health consequences were observed in 
patients who ate artificial sweeteners (Hall et al, 2017). Negative consequences included 
plaque build-up in blood vessels and the increased risk for cardiovascular disease (CVD) 
(Hall et al, 2017).  
In addition to the cardiovascular effects, there has been some study into the 
effects of consuming artificial sweeteners on more on genotoxic effects. Bandyopadhyay, 
Goshal, and Mukherjee tested mice bone marrow cells following administration of three 
artificial sweeteners (Bandyopadhya, Goshal, and Mukherjee, 2008). The artificial 
sweeteners acesulfame K, saccharin, and aspartame were given orally to an experimental 
group of 8-10 week old Swiss albino mice (Bandyopadhya, Goshal, and Mukherjee, 
2008). For aspartame, mice were divided into five groups and given 0, 7, 14, 28, and 35 
mg/kg through gastric intubation (Bandyopadhya, Goshal, and Mukherjee, 2008). 
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Acesulfame K experimental group was divided into 0, 150, 300, and 600 mg/kg and 
saccharin experimental group was divided into 0, 50, 100, and 200 mg/kg 
(Bandyopadhya, Goshal, and Mukherjee, 2008). After a period of administration of the 
artificial sweeteners, the mice were sacrificed and their cells were processed and tested 
via a comet assay to identify any genetic changes in the bone marrow cells 
(Bandyopadhya, Goshal, and Mukherjee, 2008). DNA breaks were observed in the 
regions of the bone marrow cells (Bandyopadhya, Goshal, and Mukherjee, 2008). 
Furthermore, there was difference in the effect between the three sweeteners, aspartame 
causing the least damage to the DNA out of the three sweeteners (Bandyopadhya, Goshal, 
and Mukherjee, 2008). 
Amin and AlMuzafar found that saccharin also has the potential to cause other 
biological damage in the renal tissue of rats (Amin and AlMuzafar, 2015). Rats were 
given the saccharin orally at two different dose regimens (Amin and AlMuzafar, 2015). 
For those rats given saccharin, there was significant decrease in cholesterol, LDL, and 
serum triglycerides (Amin and AlMuzafar, 2015). On the other hand, liver biomarkers 
increased in serum ALT, ALP, AST, albumin, total protein, and urea levels (Amin and 
AlMuzafar, 2015). Abhilash also found a similar effect of increased levels of alanine 
aminotransferase (ALT) and aspartate aminotransferase (AST), which are all important in 
metabolism of converting and breaking down food (Abhilash et al, 2011). The levels of 
glutathione (GSH), an antioxidant, has also been shown to be significantly decreased 
following the consumption of aspartate (Abhilash et al, 2011). Moreover, saccharin 
	24 
seemingly caused higher hepatic MDA level and a decrease in catalase and SOD 
activities, which are the signs of oxidative stress (Amin and AlMuzafar, 2015). 
 
Figure 12. Aspartame and glutathione concentration in liver of rodent models. 
Rodents who received more aspartame had a significant decrease in the amount of 
glutathione. (Abhilash et al, 2011). 
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Table 5.  Saccharin treated rats had higher levels of MDA. High concentrations of 
saccharin also caused a decrease in the levels of catalase. Futhermore, the SOD was 
decreased in the high saccharine group relative to all the other groups.  (Amin and 
AlMuzafar, 2015) 
 
            According to Adaramoye and Akanni, aspartame may also have some serious 
cellular consequences (Adaramoye and Akanni, 2016). 20 adult Wistar rats ranging from 
185 to 193 grams were assigned to four different groups, a control receiving distilled 
water and three experimental groups receiving aspartame doses of 15, 35, and 70 mg/kg 
body weight (Adaramoye and Akanni, 2016). For the two highest levels of the aspartame 
groups, there was a significant change in the weight of the brain and the liver with an 
increase in the size and weight (Adarmoye and Akanni, 2016). In addition, there was a 
decrease in the levels of antioxidants creating the potential for more adverse effects 
because of the lack of the buffering effect of antioxidants against harmful substances 
(Adarmoye and Akanni, 2016). In the liver of rodent models, reductions in the number of 
antioxidants following the consumption of aspartame were also noted (Abhilash et al, 
2011).  Furthermore, there was a reduction in the levels of multiple enzymes that 
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included catalase and glutathione peroxidase (Adarmoye and Akanni, 2016). Aspartame 
was also shown to cause a decrease in the total cholesterol and low-density lipoproteins 
(Adarmoye and Akanni, 2016). Although the results are still limited to small number of 
parameters, this result has the potential to lead to significant changes in the long run. 
 
 
Table 6. Body Weight, Relative weight of organs, and Weight of organs after 
Aspartame consumption. (Adarmoye and Akanni, 2016).  
 
            The implications for the influence of artificial sweeteners on cancer have also 
been quite alarming. Ashok and Sheeladevi tested the toxic effects of aspartame via a 
mechanism that signals the release of methanol (Ashok and Sheeladevi, 2014). From the 
increase of methanol, it was proposed that there would be an increase in the amount of 
oxidative stress for the brain (Ashok and Sheeladevi, 2014). Furthermore, the expression 
of pro-apoptic Bax and anti-apoptotic Bcl-2 along with caspase-3 could also cause an 
adverse change (Ashok and Sheeladevi, 2014). For the aspartame treated rats, there was 
increase in the pro-apoptic Bax increase while the anti-apoptic Bcl-2 was lower (Ashok 
and Sheeladevi, 2014). These results suggest that artificial sweeteners may have a role in 
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cell death that can be detrimental to the body and the normal processes of clearing 
harmful substances or growths. 
 
Behavioral vs. Biological Underlying Reasons for Adverse Effects 
There have been continuous questions as to how and why people gain weight 
when they are consuming a non-caloric substance that would seemingly not contribute 
much to a gain in weight. However, a few studies have shown very eye-opening results as 
to the potential mechanisms or reasons behind this odd trend. Furthermore, the trends 
have forced the need for identifying whether the fundamental driving force is more along 
the lines of behavioral mechanisms or actual physiological manifestations or possibly 
even both. 
 
Behavioral Explanations and Questions:  
Pinto and colleagues found that saccharin also seemed to influence how much 
energy rat subjects exerted (Pinto et al, 2017).  In their study, Pinto and colleagues 
measured the energy expenditure of rats following either sucrose and saccharin (Pinto et 
al, 2017). The saccharin group had more weight gain compared to the sucrose diet group 
and was shown to exert less energy when measured (Pinto et al, 2017). From the data, 
Pinto and colleagues concluded that the reasonable explanation was that a longer 
exposure of sucrose stimulated a greater energy expenditure (Pinto et al, 2017). On the 
other hand, the usage of saccharin may lead to the rats at rest to stop any further energy 
usage (Pinto et al, 2017). 
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Stellman and Garfinkel showed a surprising observation on the aftermath 
following the use of an artificial sweetener (Stellman & Garfinkel, 1988). According to 
the prospective study that was conducted, both male and female participants who had a 
history of consuming artificial sweeteners had a greater weight gain irrespective of the 
initial BMIs that were documented than the group that did not consume artificial 
sweeteners (Stellman & Garfinkel, 1988). Furthermore, the type of food ingested, such as 
fatty and non-fatty foods, did not influence the weight gain (Stellman & Garfinkel, 1988). 
Rather, even though the artificial sweetener group consumed more of what most people 
would consider to be health foods such as chicken and fish instead of sweets and butter, 
they were more likely to gain more weight (Stellman & Garfinkel, 1988).  
Various questions still remain on why the weight gain actually occurs following 
consumption of artificial sweeteners. According to studies with rodents, the relationship 
between consumption of sweets and the amount of calories that are consumed following 
initial consumption of an artificial and regular sweetener is differential (Davidson et al, 
2011). Davidson and colleagues initially exposed two groups to either a normal 
sweetener or the artificial sweetener saccharine (Davidson et al, 2011). Following the 
initial exposure, the rodents were given nutritive solutions that had a sweet component or 
a normative component, all being a normative nutritive value, and were taught the 
difference between the sweetened and unsweetened substances (Davidson et al, 2011).  
When first exposed to artificial sweetener, the rodents were less likely to have an 
association between sweeter substances and the metabolic consequences that normally 
arise from the consumption (Davidson et al, 2011). The saccharin group was found to eat 
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more substances with glucose following the initial exposure due to wanting to 
compensate for the lack of sweetness (Davidson et al, 2011). Although not a human 
model, it would seem plausible that this association could also explain partially the trends 
that arise in humans following consumption of artificial sweeteners. 
The predispositions may also be a key factor in determining whether or not the 
outcomes of consuming an artificial sweetener leads to weight loss or gain. In a 
secondary meta-analysis on a data set from a trial study in children, Katan and colleagues 
showed that there may be also differential outcomes in weight loss or gain depending on 
the initial BMI of participants prior to exposure of either sweeteners or artificial 
sweeteners (Katan et al, 2016). Children who had a higher BMI at the beginning of the 
trial were shown to not have the same level of compensation in terms of caloric 
consumption when compared to those who were below the median BMI level (Katan et al, 
2016).  
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Figure 13. The consumption of either glucose-paired or polycose-paired solution 
following the initial conditions of early saccharin or water exposure. (Davidson et al, 
2006) 
 
Multiple studies have confirmed that artificial sweeteners lead to hunger and 
increased appetite (Mattes & Popkin, 2009; Gardner et al, 2012). Even the simplest 
experiment using oral stimulation by aspartame has shown to increase hunger (Tordoff & 
Alleva, 1990). Study by Tordoff and Alleva took 20 participants into two groups, 10 male 
and 10 female (Tordoff & Alleva, 1990). In each group, 5 were given no gum as control 
while the remaining 5 were given gum containing 0%, 0.05%, 0.3%, 0.5%, or 1.0% 
aspartame (Tordoff & Alleva, 1990). Collectively, gums with higher concentration of 
aspartame resulted in hunger but 0.3% and 0.5% showed higher results than 1.0% 
(Tordoff & Alleva, 1990). This points out that many factors play into stimulating hunger 
such as taste, osmolarity, and liquidity of the sweetener’s substance (Tordoff & Alleva, 
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1990). Tordoff and Alleva concludes that sweetness influences appetite, which is also 
confirmed in other studies that shows saccharin increasing food intake and food 
preference in rat models (Tordoff & Alleva, 1990; Tordoff & Friedman, 1989). 
 
 
Figure 14. Oral stimulation of aspartame and hunger ratings. Solid dot represents 
female subjects while clear dots represent male subjects. Differences in sexes can be seen 
with higher sweetness rating given by male subjects. 0.3% and 0.5% resulting in greater 
hunger ratings than 1.0% shows that concentration of aspartame and hunger is not linear 
(Tordoff & Alleva, 1990). 
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Physiological Perspective Behind Choosing Sweeteners or No Sweeteners 
 
          Although the behavioral elements have been widely accepted as a plausible 
explanation on explaining the adverse effects of consuming the artificial sweeteners, the 
biological elements and the evidence that has been produced are also equally important to 
evaluate an accurate depiction of everything. Furthermore, the underlying biological 
reasons for how a difference or preference for a caloric substance over a non-caloric 
sweetener in rat studies are equally necessary to identify in order to gain a more thorough 
understanding how the biological and behavioral changes arise.  
Yasoshima and colleagues studied the different regions of the amygdala to 
determine which regions were primarily the areas that had more of a sugar preference 
(Yasoshima et al, 2015). In their study, they examined the central and the basolateral 
regions of the amygdala via “sham lesions” in these two areas (Yasoshima et al, 2015). 
When the mice with sham lesions were given training periods of either the real sucrose 
sugar or the artificial sweetener saccharine while being subjected to forced food 
deprivation, all mice showed a learned preference for the caloric solution of sucrose 
following the starvation (Yasoshima et al, 2015). However, when an excitotoxic lesion 
was placed in both the basolateral and the central regions, the results indicated a 
difference between the two groups (Yasoshima et al, 2015). Mice who were administered 
microlesions followed by an excitotoxin injection in the basolateral regions were not able 
to choose the more concentrated solution of the sucrose as the sham lesion group had 
done (Yasoshima et al, 2015). In contrast, the microlesions and the toxin injections in the 
central area of the amygdala did not yield any changes and the mice again chose the more 
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concentrated sucrose solution (Yasoshima et al, 2015). From these findings, it could be 
extrapolated that the basolateral region played a larger role in this mechanism for 
realizing the nutritive value in sucrose when compared to the artificial sweetener and 
when sucrose was compared to itself (Yasoshima et al, 2015).  
 
Figure 15. The change in the sweetener preferences. There was a positive correlation 
for preference in sucrose concentration for more concentrated basolateral cell regions 
compared to the CeA cells that seemingly did not have a positive correlation.  
(Yasoshima et al, 2015) 
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Sclafani, Zukerman, and Ackroff showed that it might not be all about the 
difference in calories that motivates a preference for caloric content but may be the actual 
glucose content in the substances offered (Sclafani, Zukerman, and Ackroff, 2015). 
According to their research, rats were initially more drawn to the non-caloric sweetener 
sucralose (Sclafani, Zukerman and Ackroff, 2015). However, in the long run, the rats 
showed an affinity for the glucose and sucrose solutions (Sclafani, Zukerman, and 
Ackroff, 2015).  
 
Metabolic Changes and Proposed Mechanisms  
From a study by Malaisse and colleagues, three types of artificial sweeteners 
induced a greater secretion of insulin (Malaisse et al, 1998). However, not all sweeteners 
induced a greater secretion of insulin (Malaisse et al, 1998). Participants that were given 
the aspartate sweetener did not have greater secretion compared to when the artificial 
sweeteners such as sodium cyclamate, sodium saccharine or stevioside (Malaisse et al, 
1998). Simon and colleagues investigated the mechanisms of how adipogenesis and the 
process of lipolysis may be influenced by artificial sweeteners (Simon et al, 2013). The 
results of these studies yielded data that was suggestive of an influence on metabolic 
processes that may not be dependent on the actual sweet receptors (Simon et al, 2013). 
According to Simon and colleagues, the T1R2 and the T1R3 G-coupled taste receptors 
were expressed during the process of apidogenesis (Simon et al, 2013). When the rat 
models were treated with saccharine, the levels of apidogenesis were higher (Simon et al, 
2013). Furthermore, lipolysis, or the process of breaking down fats, was also lower once 
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the saccharin was introduced (Simon et al, 2013). However, the influence of the artificial 
sweeteners was seemingly independent of the changes in metabolism (Simon et al, 2013).  
Furthermore, there are suggested actual physical mechanisms that could explain 
the differential metabolic outcomes that arise due to the prior exposure with either 
artificial or regular sweetener. Mitsutomi and colleagues found that, although the 
hyperglycemia seemed to have been decreased following consumption of a non-nutritive 
sweetener in rat subjects, there was some changes in the metabolism that could not be 
ignored (Mitsutomi et al, 2014). In particular, the metabolic changes were primarily seen 
in the rats that been induced into obesity through diet (Mitsutomi et al, 2014). Metabolic 
markers such as the UCP-1 were changed in the diet-induced obese (DIO) rodents 
suggesting a change in their metabolism following saccharine consumption (Mitsutomi et 
al, 2014).  
 According to Swithers and colleagues, the actual homeostasis of glucose could be 
differential relative to whether or not rodent subjects had been prior exposed to the 
saccharine sweetener (Swithers et al, 2012). Interestingly, there was a difference in the 
administration of glucose and the outcomes of the glucose homeostasis between the rats 
with prior exposure to saccharine or the group without the exposure (Swithers et al, 2012). 
In particular, when rats were given glucose orally, the rats that had been exposed to 
saccharine showed a higher level of glucose in the blood (Swithers et al, 2012). This 
effect was not witnessed when rats were given glucose directly injected into their 
stomachs suggesting a difference in the processing (Swithers et al, 2012). Moreover, the 
levels of the GLP-1 were much lower in the saccharine group compared to the non-
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saccharine group of rats (Swithers et al, 2012). Ultimately, Swithers and colleagues 
suggested that the predictive association between the sweetened flavors and the amount 
of calories may not be established (Swithers et al, 2012). 
 
 
Figure 16. Saccharin exposure and glucose exposure and consequential weight gain 
among subjects. The saccharin exposed group had higher weight gain compared to the 
glucose exposed group. (Swithers et al, 2012).  
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Discussion 
There has been growing support for the cautious evaluation of artificial 
sweeteners due to their perceived negative affect on areas such as weight gain and 
diabetes (Kuk and Brown, 2016). However, there are still published studies that have not 
been able to document any changes following consumption. Furthermore, numerous 
studies are able to still maintain the greater adversity consequential to regular sugars 
rather than artificial sweeteners. When compared to diet drinks, sugar-sweetened 
beverages have been shown to still lead to pre-diabetes and other health issues (Ma et al, 
2016). Furthermore, when measuring for difference in fatty liver disease between 
artificial sweeteners and non-artificial sweeteners, participants who had consumed the 
traditional non-artificial sweeteners had more incidents of fatty liver disease (Ma et al, 
2015).  
Studies have also shown artificial sweeteners to disrupt gut microbiota, leading to 
glucose intolerance and liver inflammation that ultimately increases the risk of obesity, 
diabetes, and cardio-metabolic problems (Suez et al, 2014; Jensen et al, 2015; Bian et al, 
2017). Rodent models have confirmed that artificial sweetener leads to dysbiosis and 
glucose intolerance, however, humans have shown to have selective response to artificial 
sweeteners (Suez et al, 2014; Bian et al, 2017). 
Although most evidence has suggested that there are, indeed, observable patterns 
of change following the ingestion of artificial sweeteners, it is still a debatable topic. 
Some studies have shown that there is a tendency to consume more calories following 
consumption of an artificial sweetener in order to compensate for a possible underlying 
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understanding and desire to compensate for the lack of calories from the artificial 
sweeteners (Davidson et al, 2011). Although this process does seemingly make sense, 
there are also contradictory measures that have shown that there may be no difference 
between consuming an artificial sweetener and a normal sweetener. In recent studies, 
individuals with similar BMI and dietary habits who were given either stevia, aspartame 
or sucrose were shown to have no difference in the appetite or feeding patterns (Anton et 
al, 2010). Furthermore, there was no difference in the satiety following the consumption 
of aspartame, stevia or sucrose foods (Anton et al, 2010). 
Saccharine and aspartame have been associated with potential differential effects 
on internal mechanisms and potential adverse consequences on the cellular and molecular 
levels for metabolic processes. Artificial sweeteners were documented to be linked with 
an increase of insulin secretion, which was harmful for the overall sugar balance within 
the body (Malaisse et al, 2018). Additionally, glucose homeostasis was observed to be 
offset following the consumption of saccharine leading to assumptions that the presence 
of artificial sweeteners can have indirect and direct influences on internal body 
mechanisms that would lead to the conspicuous changes in the body systems (Swithers et 
al, 2012). Although the natural body mechanisms seem to have a direct impact following 
the exposure to artificial sweeteners, the effects have yet to be seen on other drug 
mechanisms (Jo et al, 2017). In mice models, the drug metabolism of bupropion was 
measured by the 5 cytochrome P450 activity, which yielded no significant changes 
following consuming the saccharine (Jo et al, 2017). 
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Conclusion 
 There is still a great misconception about artificial sweeteners. The absence of 
calories may lead to think that artificial sweeteners can be a great substitute for sugary 
substances and a great alternative for overweight and diabetic patients. However, studies 
have found that artificial sweeteners result in weight gain and increase the risk of diabetes, 
which is contrary to what was believed. Both short and long-term studies associate the 
consumption of artificial sweeteners to have consequential effects leading conditions 
such as dysbiosis, overconsumption, changes in metabolic outcomes, and much more. 
However, many of these studies derive from rodent models. Further studies must include 
human subjects to confirm the findings that suggest a correlation between artificial 
sweeteners and increased risk of obesity and diabetes. Nonetheless, there is 
overwhelming data that suggest that artificial sweeteners bring potential risk to our 
overall health. Continued monitoring of artificial sweetener consumption should be 
highly enforced. 
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